Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005667 | transcription regulator complex | 2 | 1 |
GO:0005672 | transcription factor TFIIA complex | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0090575 | RNA polymerase II transcription regulator complex | 3 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: Q4Q235
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006352 | DNA-templated transcription initiation | 6 | 1 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0032774 | RNA biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.487 |
CLV_MEL_PAP_1 | 43 | 49 | PF00089 | 0.463 |
CLV_NRD_NRD_1 | 288 | 290 | PF00675 | 0.628 |
CLV_PCSK_FUR_1 | 286 | 290 | PF00082 | 0.695 |
CLV_PCSK_KEX2_1 | 288 | 290 | PF00082 | 0.573 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.470 |
DEG_APCC_DBOX_1 | 103 | 111 | PF00400 | 0.481 |
DEG_APCC_DBOX_1 | 263 | 271 | PF00400 | 0.585 |
DEG_SCF_FBW7_1 | 164 | 170 | PF00400 | 0.631 |
DEG_SCF_FBW7_2 | 131 | 138 | PF00400 | 0.584 |
DEG_SPOP_SBC_1 | 179 | 183 | PF00917 | 0.632 |
DOC_CKS1_1 | 164 | 169 | PF01111 | 0.549 |
DOC_CYCLIN_yCln2_LP_2 | 187 | 193 | PF00134 | 0.715 |
DOC_MAPK_gen_1 | 71 | 81 | PF00069 | 0.638 |
DOC_PP2B_LxvP_1 | 187 | 190 | PF13499 | 0.717 |
DOC_PP4_FxxP_1 | 206 | 209 | PF00568 | 0.532 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.668 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.569 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.632 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.706 |
DOC_USP7_MATH_1 | 210 | 214 | PF00917 | 0.505 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.589 |
DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.474 |
DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.720 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 66 | 71 | PF00397 | 0.631 |
DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.674 |
LIG_14-3-3_CanoR_1 | 104 | 108 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 71 | 81 | PF00244 | 0.556 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.471 |
LIG_deltaCOP1_diTrp_1 | 138 | 145 | PF00928 | 0.492 |
LIG_FHA_1 | 236 | 242 | PF00498 | 0.465 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.445 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.692 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.523 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.705 |
LIG_FHA_2 | 216 | 222 | PF00498 | 0.571 |
LIG_LIR_Apic_2 | 203 | 209 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 234 | 244 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 261 | 270 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 89 | 99 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 106 | 111 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 234 | 240 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 261 | 265 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 89 | 94 | PF02991 | 0.462 |
LIG_MYND_1 | 131 | 135 | PF01753 | 0.586 |
LIG_SH2_CRK | 177 | 181 | PF00017 | 0.704 |
LIG_SH2_NCK_1 | 177 | 181 | PF00017 | 0.704 |
LIG_SH2_SRC | 188 | 191 | PF00017 | 0.712 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.651 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.710 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.479 |
LIG_SH3_2 | 99 | 104 | PF14604 | 0.667 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.529 |
LIG_SH3_3 | 50 | 56 | PF00018 | 0.687 |
LIG_SH3_3 | 96 | 102 | PF00018 | 0.683 |
LIG_SUMO_SIM_par_1 | 234 | 243 | PF11976 | 0.542 |
LIG_SUMO_SIM_par_1 | 48 | 54 | PF11976 | 0.458 |
LIG_TRAF2_1 | 135 | 138 | PF00917 | 0.586 |
LIG_TYR_ITIM | 260 | 265 | PF00017 | 0.487 |
MOD_CDC14_SPxK_1 | 101 | 104 | PF00782 | 0.661 |
MOD_CDK_SPK_2 | 131 | 136 | PF00069 | 0.589 |
MOD_CDK_SPK_2 | 66 | 71 | PF00069 | 0.675 |
MOD_CDK_SPxK_1 | 98 | 104 | PF00069 | 0.669 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.662 |
MOD_CK1_1 | 160 | 166 | PF00069 | 0.587 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.693 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.683 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.494 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.614 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.701 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.715 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.549 |
MOD_GlcNHglycan | 194 | 199 | PF01048 | 0.638 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.448 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.457 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.672 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.547 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.486 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.708 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.463 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.403 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.641 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.662 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.653 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.355 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.532 |
MOD_OFUCOSY | 16 | 23 | PF10250 | 0.471 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.504 |
MOD_PIKK_1 | 274 | 280 | PF00454 | 0.637 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.588 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.452 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.461 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.561 |
MOD_Plk_1 | 220 | 226 | PF00069 | 0.656 |
MOD_Plk_1 | 235 | 241 | PF00069 | 0.541 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.471 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.538 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.654 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.356 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.530 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.586 |
MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.481 |
MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.715 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.506 |
MOD_ProDKin_1 | 66 | 72 | PF00069 | 0.630 |
MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.669 |
TRG_DiLeu_BaEn_1 | 236 | 241 | PF01217 | 0.533 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.705 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.568 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.483 |
TRG_ER_diArg_1 | 263 | 266 | PF00400 | 0.553 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P9A1 | Trypanosomatidae | 34% | 100% |
A0A3S7XAA2 | Leishmania donovani | 89% | 100% |
A4ICU4 | Leishmania infantum | 89% | 100% |